William Joseph Chapin, MD, MSCE

faculty photo
Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
10 South Pavilion
3400 Civic Center Blvd
Philadelphia, PA 19104
Education:
BS (Molecular Biology, Spanish, Honors in the Liberal Arts)
University of Wisconsin-Madison , 2012.
MD (Medicine )
The University of Chicago Pritzeker School of Medicine , 2016.
MSCE (Clinical Epidemiology)
University of Pennsylvania Perelman School of Medicine , 2022.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

William Joseph Chapin, Wei-Ting Hwang, Ronac Mamtani, and Mark H. O'Hara: Real-world comparison of low- versus high-dose continuous 5FU infusion in patients receiving triplet chemotherapy plus bevacizumab for newly diagnosed metastatic colorectal cancer (mCRC). Journal of Clinical Oncology 42(3_suppl): 62-62, January 2024.

William J Chapin, Ryan C Massa, Jennifer R Eads: Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers. Advances in Oncology. Elsevier, 2024 Notes: Article in Press.

William Joseph Chapin, Wei-Ting Hwang, Ronac Mamtani, Mark H O'Hara: Real-world comparison of triplet-versus doublet-chemotherapy with bevacizumab in patients with newly diagnosed metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. American Society of Clinical Oncology, 41(16_suppl): 3574-3574, June 2023.

William Joseph Chapin, Parul Agarwal, Lisa DiCicco, Rayleigh Palmer, Nadia Cenou, Alexander Chan Chi Huang, Thomas Benjamin Karasic: Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers. Journal of Clinical Oncology. American Society of Clinical Oncology, 41(16_suppl): TPS4184-TPS4184, June 2023.

Alese OB, Wu C, Chapin WJ, Ulanja MB, Zheng-Lin B, Amankwah M, Eads J.: Update on Emerging Therapies for Advanced Colorectal Cancer. Am Soc Clin Oncol Educ Book May 2023.

Chapin WJ, Reiss KA.: PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am Sep 2022.

Chapin WJ, Till JE, Hwang WT, Eads JR, Karasic TB, O’Dwyer PJ, Schneider CJ, Teitelbaum UR, Romeo J, Black TA, Christensen TE, Tabery CR, Anderson A, Slade M, LaRiviere M, Yee SS, Reiss KA, O’Hara MH, Carpenter EL. : Multi-analyte prognostic signature including circulating tumor DNA and circulating tumor cells in patients with advanced pancreatic adenocarcinoma. JCO Precision Oncology 6: e2200060, August 2022.

Chapin WJ, Hwang WT, Karasic TB, McCarthy AM, Kaplan DE. : Comparison of Nivolumab and Sorafenib for First Systemic Therapy in Patients with Hepatocellular Carcinoma and Child-Pugh B Cirrhosis. Cancer Medicine 00: 1-11, June 2022.

Chapin WJ, Massa RC, Eads JR: Evolving standards of care for neoadjuvant and adjuvant therapy in esophageal, gastroesophageal junction, and gastric cancer. Clinical Advances in Hematology and Oncology 19(12): 784-793, December 2021.

Chapin WJ, Hwang WT, Karasic TB, McCarthy AM, Kaplan DE: Comparative effectiveness of sorafenib, lenvatinib, and nivolumab as first-line systemic therapy for patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis treated at VA Medical Centers. American Society of Clinical Oncology Annual Meeting, Chicago, IL, USA. Jun 2021 Notes: "Virtual Poster Presentation"

back to top
Last updated: 03/20/2024
The Trustees of the University of Pennsylvania